Neuraxpharm

Greenhouse gas emissions & sustainability report data

📊 Latest report period: 2021-22🗂️ Report periods on file: 2021-22

In its 2021-22 reporting, Neuraxpharm disclosed greenhouse gas emissions of 2.4K tCO2e (2021). By scope: Scope 1: 678 tCO2e (2021); Scope 2: 1.3K tCO2e (2021). Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.

💨
GHG Emissions
2.4K tCO2e (2021)
2021-22
💧
Water Usage
34.7K m3 (2021)
2021-22
♻️
Waste
1.2K tons (2021)
2021-22
⚙️
Energy Use
9.1K MWh (2021)
2021-22

📊 Emissions by Scope (2021-22)

ScopeWhat it coversReported value
Scope 1Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions).678 tCO2e (2021)
Scope 2Indirect emissions from purchased electricity, steam, heat and cooling.1.3K tCO2e (2021)

New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.

✅ Reported Environmental Achievements

🎯 Climate & Sustainability Targets

🔜 Short-term

  • Extend support for mental health and raise awareness of CNS disorders in more countries
  • Increase usage of Coursera
  • Implement Inclusive Box
  • Design and roll out Neuraxpharm Leadership Standards
  • Redesign values & behaviours

🌱 ESG Focus Areas

Mental health and well-beingDiversity & InclusionEnvironmental Management & Climate ActionResponsible SourcingGovernance, Compliance & Ethics

⚠️ Challenges & Risks +

  • War in Ukraine and resulting energy price increases
  • Global supply chain shortages

📋 Report Information

Reporting Period: 2021-22
Frameworks: UN Sustainable Development Goals (SDGs)